Form 8.3 - Avadel Pharmaceuticals plc

27th Oct 2025 11:38

Form 8.3 - Avadel Pharmaceuticals plc

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	State Street Global Advisors & Affiliates
Company dealt in	Avadel Pharmaceuticals plc
Class of relevant security to whichthe dealings being disclosed relate (Note 2)	$0.01 ordinary shares
Date of dealing	24th October 2025

2. INTERESTS AND SHORT POSITIONS(110) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	2,288,294	2.34930%
(2) Derivatives (other than options)	N/A	N/A
(3) Options and agreements topurchase/sell	N/A	N/A
Total	2,288,294	2.34930%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	N/A
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	N/A
Total	N/A

3. DEALINGS (Note 4)(110) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit (Note 5)
Purchase	11,200	18.56
Sale	11,200	18.56

(b) Derivatives transactions (other than options transactions)

Product name,e.g. CFD	Nature of transaction(Note 6)	Number of relevant securities(Note 7)	Price per unit(Note 5)
N/A

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,e.g. call option	Writing, selling,purchasing varying etc.	Number ofsecurities to whichthe option relates(Note 7)	Exerciseprice	Type, e.g.American,European etc.	Expirydate	Option moneypaid/receivedper unit (Note 5)
N/A

(ii) Exercising

Product name,e.g. call option	Number of securities	Exercise price perunit (Note 5)
N/A

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction(Note 8)	Details	Price per unit(if applicable) (Note 5)
N/A

4. OTHER INFORMATIONAgreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

N/A

Is a Supplemental Form 8 attached? (Note 9)NODate of disclosure27th October 2025

Contact nameDivya KTelephone number

+918067452364

If a connected EFM, name of offeree/offeror with which connectedN/A If a connected EFM, state nature of connection (Note 10)N/A